Semaglutide (Glp-1 Receptor Agonist)2Mg Injectable Solution Suppliers & Bulk Manufacturers
Available Forms: Injectable solution (prefilled pen)
Available Strengths: 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 2 mg/0.5 mL
Reference Brands: Ozempic(EU & US)
Category:
Diabetes
Semaglutide is a GLP-1 receptor agonist that mimics the action of incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying, helping control blood sugar. It is used for type 2 diabetes management and chronic weight control in obese or overweight adults, improving glycemic levels and promoting satiety.
Product Description:
Semaglutide, a GLP-1 receptor agonist available as an injectable solution (e.g., Ozempic, Wegovy), is FDA-approved in the USA for type 2 diabetes and chronic weight management in adults. It requires Boxed Warnings for potential thyroid C-cell tumors and must meet GMP, labeling, and post-marketing surveillance standards. In the EU, semaglutide is centrally approved by the EMA for the same indications, with stringent requirements for Risk Management Plans (RMPs) and pharmacovigilance reporting. Ongoing clinical safety and batch quality oversight are essential in both markets. Explore compliant supply options at Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing